---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-23-000023"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2023-03-06T23:59:59+00:00"
generated_at: "2026-06-18T11:28:59.288375+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MariMed appoints Edward Gildea as Chairman and Jon R. Levine as CEO

## Summary
- Edward Gildea appointed Chairman of the Board, effective February 28, 2023.
- Jon R. Levine appointed Chief Executive Officer, effective February 28, 2023.
- Board amended Bylaws to revise powers and duties of Chairman, CEO, and President.
- Amendment to Bylaws filed as Exhibit 3.2(A) with this 8-K.

## SEC filing metadata
- accession: 0001522767-23-000023
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2023-03-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000023/0001522767-23-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000023/mrmd-20230228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-23-000023
- JSON: https://secwatch.observer/filing/0001522767-23-000023.json
- Plain text: https://secwatch.observer/filing/0001522767-23-000023.txt

## Key facts
- Governance Changes
  MARIMED INC.: Amended Bylaws to revise powers and duties of Chairman, CEO, and President (effective 2023-02-28).
  - Change: bylaw amendment
  - Effective: 2023-02-28
  source text: On February 28, 2023, the Board of Directors of MariMed Inc. (the “ Corporation ”), in conjunction with the appointment of Edward Gildea as Chairman of the Board and Jon R. Levine as Chief Executive Officer of the Corporation, authorized, approved and adopted an amendment the Corporation’s Bylaws (the “ Bylaws ”), to revise the powers and duties of the Corporation’s Chairman of the Board, Chief Executive Officer and President as set forth in Sections 4 and 5 of Article IV of the Bylaws, as amended.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000023/0001522767-23-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.